Man Group PLC Macrogenics Inc Transaction History

Man Group PLC

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	BUY	$3.01 - $5.22 $60,801 - $105,444	20,200 New	20,200 $70,000
Q1 2021 May 17, 2021	SELL	$18.99 - $33.2 $1.53 Million - $2.68 Million	-80,619 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$19.41 - $26.0 $269,352 - $360,802	13,877 Added 20.79%	80,619 $1.84 Million
Q3 2020 Nov 16, 2020	SELL	$24.69 - $31.6 $95,081 - $121,691	-3,851 Reduced 5.46%	66,742 $1.68 Million
Q2 2020 Aug 14, 2020	SELL	$5.2 - $29.12 $624,878 - $3.5 Million	-120,169 Reduced 62.99%	70,593 $1.97 Million
Q1 2020 May 15, 2020	BUY	$4.28 - $12.11 $160,260 - $453,446	37,444 Added 24.42%	190,762 $1.11 Million
Q4 2019 Feb 18, 2020	BUY	$7.95 - $12.27 $87,450 - $134,970	11,000 Added 7.73%	153,318 $1.67 Million
Q3 2019 Nov 14, 2019	SELL	$12.44 - $17.48 $2.38 Million - $3.34 Million	-191,142 Reduced 57.32%	142,318 $1.82 Million
Q2 2019 Aug 14, 2019	BUY	$14.51 - $19.71 $1.03 Million - $1.4 Million	70,874 Added 26.99%	333,460 $5.66 Million
Q1 2019 May 15, 2019	BUY	$11.11 - $25.6 $811,030 - $1.87 Million	73,000 Added 38.5%	262,586 $4.72 Million
Q4 2018 Feb 14, 2019	BUY	$11.75 - $21.42 $1.45 Million - $2.64 Million	123,464 Added 186.72%	189,586 $2.41 Million
Q3 2018 Nov 14, 2018	BUY	$19.26 - $23.46 $1.04 Million - $1.26 Million	53,906 Added 441.27%	66,122 $1.42 Million
Q2 2018 Aug 14, 2018	BUY	$19.78 - $24.67 $241,632 - $301,368	12,216 New	12,216 $253,000

132

55.4M

215K

238K

Ticker MGNX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 61,458,800
Market Cap $200M
Description
MacroGenics, Inc., a biopharmaceutical company, develops and commercializes antibody-based therapeutics to treat cancer in the United States. Its approved product is MARGENZA (margetuximab-cmkb), a human epidermal growth factor receptor 2 (HER2) receptor antagonist indicated, in combination with chemotherapy, for the treatment of adult patients ...

Get notified when there are updates to the investment portfolio of Man Group PLC, based on Form 13F filings with the SEC.

Stay updated on Man Group PLC with notifications on news.